/ /

  • linkedin
  • Increase Font
  • Sharebar

    Glaucoma management can play important role with premium IOLs

     

    Providing premium IOL care

    Patients want premium IOLs. They want better vision and they do not want to use drops. Word of mouth is powerful, and patients who hear about a procedure that will reduce or eliminate drops will come.

    Physicians need to stay up-to-date, both to remain relevant in today’s world and to provide the best possible care for patients. It is imperative to keep up with the times and changing technology to better serve the patients.

    If a surgeon has abandoned the technology because of problems inserting the stent, I recommend working with a successful surgeon on the technique and try again. Both physicians and patients will find it worthwhile.

    In today’s environment, not offering a MIGS procedure to a patient who is undergoing cataract surgery is a missed opportunity. In the United States, most MIGS procedures are indicated during cataract surgery.

    If that window is missed, surgeons have missed this opportunity to help the patient. Physicians should do all in their power to help patients. Therefore, when implanting an IOL to improve patient vision, surgeons cannot forget to treat the glaucoma as well.

    References

    1. Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE, US iStent Study Group.  Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 2011;118:459-467.

    2. Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, et al. Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br J Ophthalmol. 2012;96(5):645-9.

    3. Fea A. M., Consolandi G., Zola M., et al. Micro-bypass implantation for primary open-angle glaucoma combined with phacoemulsification: 4-year follow-up. Journal of Ophthalmology. 2015;2015:4. doi: 10.1155/2015/795357.795357

    4.  Neuhann T. H. Trabecular micro-bypass stent implantation during small-incision cataract surgery for open-angle glaucoma or ocular hypertension: long-term results. Journal of Cataract & Refractive Surgery. 2015;41(12):2664–2671. doi: 10.1016/j.jcrs.2015.06.032.

    5. Malvankar-Mehta M. S., Iordanous Y., Chen Y. N., et al. iStent with phacoemulsification versus phacoemulsification alone for patients with glaucoma and cataract: a meta-analysis. PLoS ONE. 2015;10(7) doi: 10.1371/journal.pone.0131770.e0131770.

    Jeffrey Whitman, MD

    e. [email protected]

    Jeffrey Whitman, MD, is a board-certified ophthalmologist and president and chief surgeon at the Key-Whitman Eye Center, Dallas, TX. He is also board certified in cataract surgery and LASIK by the American Board of Eye Surgeons. Dr. Whitman is the president for the Outpatient Ophthalmic Surgery Society.

     

    New Call-to-action

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Poll

    View Results